'Oxford Vaccine Covishield To Cost Rs 200 Per Vial', Says Serum Institute Of India
ABP News Bureau | 11 Jan 2021 06:05 PM (IST)
Serum's 'Covishield' vaccine would be available at the price of ₹200 per vial, central government has signed the purchase order, said SII officials.

Image: AFP
As India is all set to rollout Covid vaccines on January 16th, the Serum Institute of India which is manufacturing 'Covishield vaccine' said on Monday that the cost per vial of the vaccine will be Rs 200 a vial after a price agreement was arrived at with the government, The first 100 million doses will be priced ₹ 200, said SII, and the initial tranche to be supplied is expected to be 11 million doses. Also Read|Indian Vaccine More Cost-Effective Than Others, Health Workers Will Be Given Priority: PM Modi "Serum Institute of India (SII) has received a purchase order from Government of India," said SII officials. The drug is expected to roll out of SII's Pune facilities by tomorrow morning as quoted by ANI. The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.